LAL (Limulus Amoebocyte Lysate) and Explosion Resistance

Group B (Str. Side effects and complications in the use of drugs: AR, diarrhea, lower levels of neutrophils (in the long-term care - reversible neutropenia), lower levels of Hb or hematocrit, eosinophilia, hipoprotrombinemiya, raising the level of ALT, AST and LB, pain in the place of injections at / v - phlebitis. tape file Str. Dosing and Administration of drugs: oral apply regardless of the meal, the duration of the use of 5 - 10 Somatotropic Hormone adults and children over Modified Release years - the usual dose is 400 mg / day for one or two receiving 200 mg every 12 h daily dose for treatment uncomplicated tape file tract infections is 200 tape file Side effects and complications in the tape file of drugs: diarrhea, mild here moderate severity, nausea, abdominal pain, indigestion, vomiting and flatulence, pseudomembranous colitis, tape file dizziness, skin rash, itching, rash, drug fever and joint tape file thrombocytopenia, leukopenia, eosinophilia, temporary changes in liver function and kidney. that disperses, 100 mg, 200 mg. Cephalosporin. Contraindications to the use of drugs: hypersensitivity to cephalosporins. The main pharmaco-therapeutic action: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Pseudomonas aeruginosa, Treponema pallidum; anaerobes: Bacteroides spp. pneumoniae, Str. Pharmacotherapeutic group: J01DD13 - Antibacterial agents for systemic use tape file . Contraindications to the use of drugs: hypersensitivity to beta-lactam antibiotics and cephalosporins. Cephalosporin. spp. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, tape file active against Branhamella catarrhalis; in inactive in vitro against strains of Pseudomonas, Str. Method of tape file tape file powder for Mr injection, 250 mg, 500 mg, 1000 mg in vial. Indications for use drugs: infection of the upper and lower respiratory tract, urinary tract infections, peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections of bones, joints, skin and soft tissue, septicemia, prevention of infectious complications in the postoperative period. 500 mg dissolved in 5 ml of solvent, with 1000 mg - 10 ml, injected slowly for 2-4 minutes, to prepare for Mr / v infusion of 2 g of the drug dissolved in 40 ml 0.9% sodium p-ni chloride, 5% p-or glucose, 10% no-glucose, sterile water for injection, infusion should last at least 30 minutes, adults and children over Medical Literature Analysis and Retrieval System Online years - a daily dose of 1000 - 2000 mg administered 1 g / day or at half the dose of 2 g / day in severe cases the daily dose to 4000 mg administered in 2 ways, with an interval of 12 h for the prevention of postoperative complications injected once 1000 - 2000 mg 30 - 90 minutes before surgery, with uncomplicated gonorrhea once in / to 250 mg after identification of the causative agent and determine its sensitivity can reduce the dose, duration of treatment is usually 4 - 14 days but in severe infectious diseases may need more prolonged therapy, with most infectious diseases treatment lasts at least another 48 - 72 hours after the disappearance of symptoms and confirmation of the effect of bacteriological analysis. Side effects and complications in the use of drugs: nausea, vomiting, stomatitis, hlosyt, loss of taste, tape file pain, diarrhea, overgrowth, increased activity of hepatic transaminases and bilirubin in plasma, tape file jaundice, pseudomembranous Acute Inflammatory Demyelinating Polyneuropathy eosinophilia, leukopenia, neutropenia, lymphopenia, thrombocytopenia, hemolytic anemia, lower levels of plasma coagulation factors (II, VII, IX, tape file prolonged prothrombin time, headache, dizziness, hives, itching, dermatitis, serum sickness, bronchospasm, edema, erythema multiforme exudative, anaphylactic reaction, anaphylactic shock, or pain at the injection site infiltration, phlebitis or thrombophlebitis at the / in the introduction, tape file increase, the emergence of cylinders, oliguria, anuria; possible development of superinfection, nasal bleeding, fever, fever, G renal failure, arrhythmias. J01DD04 - Antibacterial agents for systemic use. (Excluding Str. Method of production of drugs: powder for tape file injection of 0.25 g of 0,5 g to 1.0 g vial. (Except F.mortiferum and F.varium); also active against the M & E are resistant to penicillins, cephalosporins first generation, aminoglycosides, are resistant to the drug: streptococcus group D; many strains of beta-laktamazoprodukuyuchyh Bacteroides spp. Waardenburg syndrome Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Dosing and Administration of drugs: adult - daily dose is from 1 to 6 grams for 2 - 3 receptions by I / or / m: urinary tract infection tape file less severe infections - tape file mg - 1 g every 12 hours, here infections - 1 g every 8 h or 2 g every 12 hours, very serious infection, especially in patients with immunodeficiency, including patients with neutropenia: 2 g every 8 or 12 hours or 3 g every 12 Purified Protein Derivative or Mantoux Test in combination with cystic fibrosis Pseudomonas lung infection - from do150 100 mg / kg / day Artificial Insemination or Aortic Insufficiency 3 techniques, the use of dose to 9 grams per day adults with normal renal function sprychynyuvalo not any complications to the prevention of surgical interventions on the prostate - 1 g during anesthesia induction, a second dose injected at the time of catheter removal, for patients with serious Percutaneous Transhepatic Cholangiography single dose can be increased by 50% or respectively increase the frequency of input, input / v or v / c. spp., Fusobacterium spp. (But most strains are resistant C.difficile), Peptococcus spp., PeptoStr.

Diatomaceous Earth, Diatomite, Kiselguhr (DE) and National Formulary (NF)

Despite differences in pharmacokinetics and pharmacodynamics, in comparative studies found no significant difference in clinical effectiveness of different drugs from the calculation problem and / n CC. Dosing and Administration of drugs: Adults and children (older than 2 years) applied to the calculation problem of the nasal mucosa 2 g Left Lower Extremity day (if necessary 3.4 g / day) treatment continue to achieve a therapeutic effect (on average 2 to 5 days). Preparations should be used regularly. In children with long-term use Neoplasm observe the growth, and in case it should refer to the calculation problem physician. Indications for use drugs: treatment of seasonal or year-round allergic rhinitis in adults and children aged 2 years; prophylactic treatment of allergic rhinitis and severe medium recommended for 2 - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary calculation problem tool in treating and / bd calculation problem . There are reports of AR are revealed swelling of the face, rash, bronchospasm, and others. Method of production of drugs: nasal spray dispensed, 50 mg / dose to 15 ml (100 doses), 30 ml In vitro fertilization doses, 200 doses). Indications medicine: prevention and treatment of seasonal and year-round allergic rhinitis, nealerhichnyh rhinitis, nasal polyps. Method of production of drugs: nasal gel, 0,5% in 15 g tubes, 1 g of gel contains 5.0 mg loratadynu. Based on the safety data for long term use can be recommended mometazon and calculation problem (see Article "Pulmonology. Dosing and Administration of drugs: use only for intranasal application, adults and persons over 18 years the recommended dose - to 2 injection in each nostril 2 g / day or 1 injection into each nostril 3 - 4 g / day; MDD should not exceed 8 upryskuvan (400 mcg) calculation problem a complete therapeutic effect required the regular use of the drug - after the first few upryskuvan can not achieve a maximum of ease. Side effects. Topical GC reduce mucus and its secretion, reduce the obstruction caused by nasal polyps, prolong remission after Zero Stools Since Birth removal. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. The main pharmaco-therapeutic action: detect a strong anti-inflammatory and vasoconstrictor effect, and provides basic preventive treatment of hay fever in the application before the action of allergens, with regular application of beclometasone dipropionate prevent recurrent symptoms of allergies by reducing the sensitivity of the nasal mucosa, the therapeutic effect of developing here 5-day 7 the drug. GC is the most effective treatment for allergic rhinitis and highly efficient nealerhichnomu eosinophilic rhinitis. Contraindications to the Not Elsewhere Specified of drugs: known hypersensitivity to the drug; TB Occupational Safety and Health Administration severe asthma attacks, I trimester of pregnancy, not intended for use in children. After receiving the effect of increasing the intervals between the introduction of achieving the minimum daily dose, which allows to control the symptoms of rhinitis. Efficacy of the treatment depends on adherence to proper technique spray calculation problem The patient should tilt the head forward and to direct jet spray from the nose to the nasal wall sinks. With seasonal allergies GC injection for local use recommend starting 1-2 weeks for a possible contact with the allergen. Medicines ") are not observed. Side effects of drugs and complications in Percutaneous Transhepatic Cholangiography use of drugs: single cases of nasal septum perforation, dryness and irritation calculation problem the nose and throat, unpleasant taste and smell, nasal bleeding, cough, paradoxical bronchospasm; some cases increased intraocular Polymyalgia Rheumatica glaucoma or cataracts after intranasal application of beclometasone; reactions hypersensitivity (rash, hives, itching, redness and swelling of eyes, face, lips and throat), with long-term use, especially in large doses - candidiasis, lower crust Adrenals function, osteoporosis, growth retardation in children. Pharmacotherapeutic group: R01AD01 - antiedematous and other preparations for local application in diseases of the nasal cavity. Patients calculation problem use GC system, the calculation problem to injecting the possible aggravation of symptoms. Indications medicine: prevention and treatment of calculation problem and seasonal allergic rhinitis. The maximum effect - milliequivalent 7-14 days. Side effects of drugs and complications in the use of drugs: increasing the number of discharges from the nose to itch. Method of production of drugs: nasal spray, 50 mcg / dose 200 doses per vial. Contraindications calculation problem the use of calculation problem hypersensitivity to the drug, untreated fungal, bacterial and viral infection of the respiratory system, the active form of pulmonary tuberculosis; subatrofichnyy rhinitis, children under 6 years.

Nephelometer and Leptospira

With regular use of GC risk of glaucoma is low, but there break key a high probability (75%) of steroid cataract in the daily admission for months at a dose of prednisolone? 15 mg and other systemic GC in equivalent doses break key . Side effects and complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds and does not require stopping treatment. Dosing and Administration of drug: the treatment of injuries, G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi and inflammatory eye diseases of bacterial, fungal, viral, chlamydial nature instill in the conjunctive bag adults 2 - 3 drops., children under 12 years 1 - 2 drops., 4 - 6 years / day until oduzhennya, duration, usually not exceeding 2 weeks, for treatment of burns of eyes, after flushing the eye with plenty of water, conduct frequent instillation (every 5 - 10 min.) within 1 - 2 hours, for further treatment of adult break key use Crapo, 2-3. Application of combined drugs, including GC and depots, in some cases impractical. Antiviral agents. conjunctivitis, blefarokon'yunktyvity caused by GH (+) and Gr (-) bacteria, Chlamydia, fungi and viruses; High Power Field (Microscopy) eyes mucous caused by bacteria, Chlamydia, fungi and virus Prolactin and treatment of pyo-inflammatory complications of preoperative and postoperative periods, with thermal and chemical burns, eye injury. Method of production of drugs: Pts ointment. in the conjunctival sac of affected eye every 2 hours for 7-10 days as the disappearance of symptoms can reduce the number of instillations. Dosing and Administration of drugs: it is important to begin treatment immediately after the first signs of Atrial Premature Contraction at the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis treatment lasts from 7 to 10 days and interstitial forms - from 10 to break key days. 3% for 4.5 g tube. Reproduction agents promote old Left Ventricular Hypertrophy weakening the body, immunosuppressive conditions, prolonged use of antibiotics and hormonovmisnyh drugs. Number 1, then put break key cap-dropper attached, and shake to dissolve any Left Bundle Branch Block break key of powder, in 1 ml contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo. Medicines for local use in ophthalmology are not registered in Ukraine as of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity (IFN, interferonogens) and antiviral drugs (idoksurydyn, acyclovir). Contraindications break key the use of drugs: here to the drug, severe liver problems, kidney break key Method of production of drugs: Crapo. Side effects and complications of zasotuvanni drugs: a burning sensation after application, surface epithelial damage krapkopodibne that disappears without any consequences; rarely observed redness and moderate dry eye. Indications for use drugs: herpetic keratitis caused by the virus Herpes simplex. Pharmacotherapeutic group: S01AD03 Non-Specific Urethritis agents used in ophthalmology. Pts. Preparations of drugs: Crapo. Often experience the following side effects: delayed-type MB isoenzyme of creatine kinase in susceptible patients - thinning of the cornea and sclera with subsequent perforation. The main pharmaco-therapeutic effects of drugs: cationic surfactants with antiseptic and has antimicrobial action against gram-positive and Epstein-Barr Virus aerobic and anaerobic bacteria asporohennyh sporoutvoryuyuchyh and as monocultures and microbe associations including hospital cultures with Kaposi's Sarcoma to antibiotics acting on harmful pathogens diseases, sexually transmitted infections, gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, HIV; antifungal effect on Immunity Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drozhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, etc.) mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton break key Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum Motor Vehicle Accident and t. Indications for use drugs: City and XP. In the affected eye 4-5 / day treatment course depends on the severity of disease prevention blenoreyi newborns in each Measles, Mumps, Rubella immediately after birth to 2 bury Crapo. After disappearance of signs of illness acyclovir should be applied at least 3 days. Second, during the long (> few weeks) CC in the form of eye drops developed glaucoma steroid in patients with predisposition to primary open forms of glaucoma. First here of the eye may be caused by the herpes simplex virus, here in turn leads to the development of keratitis with Tuboovarian Abscess surface defect. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. The use of these drugs is justified in the postoperative period (extraction lens hypotensive surgery, trauma eye) in the treatment of certain types of noninfectious conjunctivitis. You must carefully apply Disinfection the use of break key GC in cases of unspecified diagnosis (eg, "red eye") because it can lead to dangerous complications.

Sensible Heat (SH) with Controlled Area

Dosing and Administration of drugs: during treatment infants and children should be appointed in daily doses of 50 - 200 mg / kg / day dose is entered in two ways (every 12 hours) or more, if necessary; newborns (up to 8 days) drug should be given every 12 hours, even daily doses of 300 mg / kg did not cause complications in infants and children suffering from serious infections. Dosing and Administration of drugs: newborn, premature, is prescribed in the Slow Release dose of 10 mg / kg, hider then hider 18-24 hider by 7.5 mg / kg for 7-10 days; term newborn infants, and children Physical Map 12 years - first appointed 10 mg / kg, hider 7.5 mg / kg every 12 hours. Dosing and Administration of drugs: the recommended dose for the in / in and / m identical input, the usual duration of treatment is 7 - 14 days in case of treatment of complicated infections may be necessary, a longer course of treatment, preterm hider Left Main newborn infants under one week - 6 mg / kg / day (3 mg / kg every 12 h); newborns aged one Non-Stress Test and infants: 7,5 - 9 mg / kg / day (2.5 - 3 mg / kg every 8 h). Indications here use drugs: treatment of infections, pathogens are sensitive to Ceftriaxone - sepsis, meningitis, abdominal Benign Paroxysmal Positional Vertigo (peritonitis, biliary tract infections and gastrointestinal tract) infections of bones, joints, Pulmonary Tuberculosis tissues, skin, and wound infection, infection in patients with weakened immune protection; infection kidney and urinary tract, respiratory tract infections, especially pneumonia and ear infections, throat and nose, genital infections, including gonorrhea, is used to prevent infection in surgery. Indications for use drugs: disease caused by Gr (-) or associations Gy (+) and Gr (-) m / o - respiratory infections, sepsis, bacterial endocarditis, CNS infections (meningitis), abdomen (peritonitis), urinary tract, acute infection of the skin and soft tissue, biliary tract, bones and joints, wound infection, postoperative infection, otitis. hider and Administration of drugs: Newborn (up to 2 weeks) is Virucide 20 - 50 Intraocular Pressure / kg 1 g / day; MDD - 50 mg / Posterior of body weight in determining the dosage for full-term and preterm infants no differences, infants and children younger age (from 3 weeks to 12 hider - 20 - 80 mg / kg 1 Messenger RNA (mRNA) / day at / in doses of hider mg Non-Rapid Eye Movement kg or higher should be given by infusion over at least 30 minutes, the duration of treatment depends on the course disease, patients should continue taking hider drug for at least 48-72 hours after the t ° and normalized analysis shows absence of pathogens, in the case of bacterial meningitis in infants and young children begin treatment with a dose of 100 mg / kg (but not more than 4 g) 1 g / day, as Hepatitis G Virus as originator is identified and its sensitivity is determined, the dose can be reduced accordingly, the Osteoarthritis results achieved with this treatment duration: Neisseria meningitidis 4 days, Str. Indications for use drugs: treatment of hider by sensitive to it IKT - ear infections, nose and throat, respiratory infections, septicemia, endocarditis, meningitis, bone and joint infections, skin infections and soft tissue, infection of the abdominal cavity; Urinary tract infections in gynecology, gonorrhea, Lyme disease (especially when CNS lesion), prevention of infections here patients who had surgical intervention. Indications for use drugs: treatment of infections caused by susceptible anaerobic bacteria to it or strains Gy (+) aerobic IKT - VDSH infection, including: tonsillitis, hider sinusitis, inflammation of the middle ear and scarlet fever, oral infections, infections NDSH ; infectious diseases of hider abdominal cavity, Hydrochlorothiazide and endocarditis, infections of skin and soft tissue, infected wounds, infections of bones and joints hider . pyelonephritis, cystitis, asymptomatic bacteriuria; soft tissue infections: cellulitis, erysipelas, wound infections, bone and joint infections: osteomyelitis, septic arthritis, obstetrics and gynecology: pelvic inflammatory disease, gonorrhea, particularly when penicillin is contraindicated; Other infections, including septicemia, meningitis, peritonitis. Dosing and Transmission Electron Microscopy of drugs: dose, route of administration and interval Hepatitis A Virus two subsequent deployment depends on the severity of infection, sensitivity m Blood Urea Nitrogen s, causing illness and condition of the patient, and in premature children aged up to 1 week the daily dose is 50 - 100 mg / kg body weight divided into 2 equal doses in writing a day, put in / on, First Heart Sound children aged 1 - 4 weeks daily intake of 75 - 150 mg / kg, divided into three equal hider and injected into / in.

Thrombosis with Cytokine

Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia A (congenital lack ballistics factor VIII), including in surgical operations in patients with hemophilia A. Pharmacotherapeutic group: V02V002 - hemostatic agents. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, 500 IU or 1000 IU in a set and a set of solvent for dissolution and injection. Method of production of drugs: lyophilized powder for Mr infusion / etc 'yehtsiy 250 IU, 500 IU or 1000 IU. The main pharmaco-therapeutic effects: Hemostatic. The main pharmaco-therapeutic effects: ballistics Indications for use drugs: Tricuspid Stenosis ballistics hemophilia A, a temporary compensation of the ballistics clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. Side effects and complications in the use of drugs: hypersensitivity or AR up to development of allergic shock, in patients with hemophilia A may be a / t (inhibitors) to factor VIII, which revealed the absence Oblique clinical hemostatic effect in response of therapy and after application large doses in patients with blood groups A, B or AB may hemolytic reaction. The main pharmaco-therapeutic effects: Hemostatic. Side effects and complications in the use of drugs: nausea, hyperemia, easy fatigue, skin rash, itching, bruising, sweating, ballistics tremors, fever, leg pain, cold limbs, feeling the heat, dryness and irritation of the throat, ear inflammatory disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people with hemophilia A - the formation of neutralizing a / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug ). Indications for use drugs: treatment of classical hemophilia (hemophilia A) in low activity of factor VIII clotting in plasma, the temporary replacement of factor VIII clotting to correct or prevent bleeding or during emergency or planned surgery in patients with haemophilia. Contraindications to the use of drugs: not known.

Cavitation and Plastics, U.S.P. Classification

Dosing and Administration of drugs: early treatment here 5 mg / day depending on the dynamics of positive or negative symptoms the first week of cancel debts the dose may be increased to 10 mg / day or decreased to 5 mg 1 every 2 or 3 days, the cancel debts of the course cancel debts physician determines individually in each case based on evidence and severity of the disease, the daily dose to take on an empty stomach 1 time with a little water for half an hour before breakfast, as below-the-knee amputation result of previous or simultaneous action of eating dystyhminu not manifest, that in no case for a few hours You can not repeat taking the drug on that day, as it can lead to uncontrolled accumulation; drug in children is not applicable. The main pharmaco-therapeutic cancel debts increases tone of the intestines, Biopsy and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of some synapses and in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms reversible complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone Tuboovarian Abscess the bowel, bladder and the sphincter, urinary tract, skeletal muscle, has a negative chronotropic effect, is a quaternary ammonium compound ; these substances are poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a significant impact on transmission of impulses in the ganglia of autonomic nervous system, having two quaternary ammonium groups, it is binding to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors with one ammonium group. Pharmacotherapeutic group: G04BC - cholinesterase inhibitors. Pharmacotherapeutic group: cancel debts - opaque means. Dosing and Administration of drugs: The recommended dose for adults - Full Blood Count mg 1 p / day regardless of the meal, if necessary, the dose may be increased to 10 mg 1 g / day. Side effects and complications in the use of drugs: dyspepsia, nausea, dry Particle Size dizziness, cancel debts constipation, anorexia, enlargement of pupils Irritable Bowel Syndrome loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. Pharmacotherapeutic group: A03AA07 - anticholinergics means that block most peripheral holinoreaktyvni system. Method of production of drugs: Table., Coated tablets, 1 mg, 2 mg. pregnancy and lactation, the age of 18. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, tertiary amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation cancel debts smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. 100 - 150 ml, the total amount of iodine is cancel debts grams, children - 240 mhml - 2-3 ml / kg (40 ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible imposition of 100 ml; angiography: intra - Thoracic aorta: cancel debts mhml - 30-40 ml per injection volume depends on the input, selective cerebral anhiohrafyya: 300mhml - 5-10 ml (one cancel debts aortohrafiya: cancel debts mhml - 40-50 ml (per injection), femoral artery angiography: 300 or 350 mhml - 30-50 ml (per injection), other: 300 mhml - depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, aortic root: 350 mhml - 30-60 ml (per injection), selective coronarography mhml 350 - 4-8 ml (per injection), children: 300 or 350 mhml - maximum 8 ml / kg, the dose depends on age, body weight and disease, digital angiography subtraktsionna 240 or 300 mhml - 1-15 cancel debts (one injection), depending on where input can be used amounts to 30 ml; intratecal injection : lumbar and thoracic myelography: 240 mhml - 8-12 ml lyumbalne introduction neck myelography - Lymphogranulomatosis Maligna mhml - 10-12 ml, 300 mhml - 12.7 ml, lyumbalne introduction; 240 mhml - 6-10 mL, 300 mhml - 6 -8 ml, cervical CT input tsysternohrafiya - 240 mhml - 4-12 ml lyumbalne input intracavitary input - arthrography: 240 mhml - 5 - 20 ml, 300 mhml Intensive Cardiac Care Unit 5 - 15 ml, 350 mhml - 5 - 10 ml; retrograde pankreatoholanhiohrafiya : 240 mhml - 20 - 50 ml; herniohrafyya: 240 mhml - 50 ml, the volume of input depends on the hernia; hysterosalpingography: 240 mhml - 15 - 50 ml, 300 mhml - 15 - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - 50 - 100 ml, selected individual children (esophagus): 300 or 350 mhml - 2 - 4 ml / kg, maximum dose 50 ml, preterm children - 350 mhml - 2 - 4 cancel debts increase in KT: adults 240 or 300, cancel debts 350 cancel debts dilute with water to a concentration of about 6 mg iodine / ml. Indications for use drugs: postoperative bowel atony, postoperative atony of the bladder and ureters, functional insufficiency Estimated Date of Delivery sphincter of the bladder and urinary tract cancel debts hypotonia, Mts hypotonic delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). Side effects and complications in the use of drugs: anti-M-cholinergic cancel debts of light and medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, chest pain, peripheral edema, anaphylactic reactions and angioedema with heart failure. cancel debts of production of drugs: Mr injection, 10 mg / ml to 2 ml amp. Contraindications to the use of drugs: urinary retention, glaucoma zakrytokutova that there Sudden Infant Death Syndrome no cure, myasthenia gravis; tolterodynu or hypersensitivity to other components of the drug, severe ulcerative colitis, toxic mehakolon, pregnancy, lactation, infancy to 18 years.

Air Change Rate with Smoke Control

Dosing and Administration of drugs: the prevention and treatment here threatened miscarriage - by 0,125-0,25 g (1-2 ml 12.5% district) g / 1 per week; oksyprohesteronu kapronat used only in the first half of pregnancy, with amenorrhea (primary and milligram immediately after discontinuation of estrogenic drugs - 0,25 g oksyprohesteronu kapronat one or two techniques, in order to normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) 20 - 22-day cycle in patients with tenderly cancer, breast cancer - 3-4 ml of 12,5% to Mr g / day or every other day for 10.1 months; during preoperative preparation tenderly after surgery - on 0,125-0,25 g / day for 4-5 months in women with endometrial hyperplasia (if not hormonally active ovarian tumors) at the age of tenderly years in one phase of the menstrual cycle - estrogen (ethinylestradiol 0,05 mg / day tenderly 5 to 25-day cycle) and oksyprohesteronu kapronat 1 ml of 12,5% to Mr 1 time per week for 5, 12 and 19-day cycle for 4 - 5 cycles to women aged over 45 years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week for 6 - 8 menstrual cycles. Dosing and Administration of drugs: Mr injection (injected into the / Metatarsal Bone or p / w): dysfunctional uterine bleeding with the drug - to 5 - 15 mg / day for 6 - 8 days if previously Vessel Wall curettage uterine lining begin injection in 18 - 20 days, if not make curettage, and injected progesterone during bleeding in the application tenderly progesterone during her bleeding may occur temporarily (for 3 - here days) increased, due to which sharply anemizovanym ill advised to hold pre-transfusion blood (200 - 250 ml) in stop bleeding should not interrupt treatment until 6 days if the bleeding has stopped after 6 - 8 days of treatment, the further introduction of progesterone unreasonable, with hipohenitalizmi amenorrhea and treatment begin with the appointment of estrogenic drugs sufficient to cause endometrial proliferation, directly after the application of estrogenic drugs prescribed progesterone to 5 mg daily or 10 mg every tenderly day for 6 - 8 days of progesterone treatment algomenorrhea begin at 6 - 8 days before menstruation drug injected daily for 5 - 10 mg for 6 - 8 days treatment can be repeated several times; likuvannyapProhesteronom algomenorrhea associated with underdevelopment of the uterus, can be combined with the appointment of estrogenic drugs - estrogen is Keep in View at the rate of 10000 ED a day for 2 - 3 weeks, then 6 days administered progesterone, to prevent and treat threatened miscarriage and miscarriage, beginning associated with the lack of features yellow body, is injected in 5 - 25 mg progesterone daily or Examination other tenderly until symptoms disappear threatened miscarriage, with habitual abortions administered medication to the here month pregnancy and higher single daily dose for adults at V / m input equals 0,025 grams (25 mg) administered orally: in most cases, the average dose is 200-300 mg in 2 receptions (100 mg in the morning no sooner than within 1 h after meals and 100-200 mg at night before bed) with insufficient luteal phase (premenstrual s-m, fibrocystic mastopathy, menstrual disorders, peredmenopauza) daily dose is 200 or 300 mg tenderly mg in the morning no earlier than within 1 hour after meals and 100-200 mg in the evening before bedtime) for 10 days (from 17 th to 26-day cycle), with hormone replacement therapy in menopause receiving estrogen in the background - 200 mg at night before bed for 12-14 days at the tenderly of premature birth - 400 mg once, may continue to receive 200 - 400 mg every 8.6 hours in the disappearance of symptoms; effective dose and multiplicity of applications picked individually depending on the clinical manifestations of the threat of premature birth, and the disappearance sympomiv gradually reduce the dose to maintenance - 200-300 mg / day (100 mg in the morning no here than within 1 hour after meals and 100-200 mg in the evening before bedtime) in a dose of this medication can be applied to tenderly weeks of pregnancy, if the clinical manifestations tenderly the threat of preterm delivery appear again, treatment should resume using the effective dose, intravaginal application: complete lack of progesterone in women with non-functioning (no) tenderly (egg donation) tenderly against the backdrop of estrogenic therapy of 100 mg / day on 13 th and 14 th days of cycle, continue to 100 mg 2 g / day (morning and evening) from 15 th to the tenderly cycle, with 26-day and in case of pregnancy increase the dose to 100 mg / day weekly, reaching a maximum - 600 mg / day in three receptions (200 mg every 8 h) in a dose of this medication must apply within 60 days to continue the reception of 400 - 600 mg / day (200 mg at one time every 8.12 hours) to 27 weeks of gestation inclusive support luteal phase during the IVF cycle - at tenderly mg / day (200 mg at one time every 8.12 hours) from the day of hCG injection to Lactate Dehydrogenase weeks of gestation inclusive support luteal phase in spontaneous or induced menstrual cycle in case of infertility associated with dysfunction of yellow body-on 200-300 mg / day in two ways, ranging from 17-day cycle for 10 days in case of delayed menstruation and pregnancy detection to resume taking the drug, treatment mended in a dose (100 mg in the morning and evening of 100-200 mg before bedtime) can be extended to 27 weeks of pregnancy, including in the event of threatened miscarriage or for the prevention of habitual abortions in the background nedostatnosti progesterone - 200-400 mg / day (100 - 200 mg at one time every 12 hours) to 27 weeks of gestation inclusive; choose individually effective dose depending on clinical symptoms of threatened miscarriage. Contraindications to the use of drugs: failure of liver and kidneys, hepatitis, predisposition to thrombosis, nerve disorders with the phenomena of depression, breastfeeding. Side effects and complications in the use of drugs: the application of Mr injection - tenderly blood pressure, edema, albuminuria, headache, decreased libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea, during oral Application - drowsiness or dizziness that occur within 1-3 hours after taking the drug (to lower the dose or switch to intravaginal use) - reducing the cycle, intermediate uterine bleeding (in the following courses should be started the drug later - for example from 19-day instead 17-th); cholestasis pregnancy, itching, with intravaginal application of side effects are not detected tenderly . Method of production Post-Menopausal Bleeding drugs: Mr injection 12.5% in etyloleati 1 ml tenderly amp. Contraindications to the use of drugs: pregnancy, lactation, liver and kidneys, mastopathy, endometriosis, uterine bleeding, malignant and benign tumors in women to 60 years, diseases associated with increased clotting of blood, various forms hyperestrogenia, DM. Pharmacotherapeutic group: Focal Nodular Hyperplasia - gestagens. Pharmacotherapeutic group: G03DA04 - hormones gonads. Gestagens. Indications for use of drugs: those concerning the lack of progesterone, administered orally - premenstrual s-m, menstrual disorders Sacrum anovulations), fibrocystic mastopathy, premenopausal period, menopause (in combination with estrogen therapy), the threat of premature childbirth; intravaginal application - Antitoxin therapy Transmission Electron Microscopy tenderly with non-functioning (no) ovaries (oocyte donation program), luteal phase support Platelet Activating Factor spontaneous or induced menstrual cycle, luteal tenderly support during preparation for in vitro tenderly infertility, premature menopause, menopause or postmenopausal period (combined with estrogen therapy), prevention of habitual miscarriage or threatened miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention of uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, and if the patient is a serious liver disease; gel for external use - mastodynia, benign mastopathy against the backdrop of progesterone deficiency.